Presentation Information
[28P2-am1-018]NMR-based drug design of the entry inhibitor of SARS-CoV-2 targeting the interaction between SARS-CoV-2 spike protein and hACE2
○Mariko Yokogawa1, Mahoro Horiuchi1, Syunki Kaneichi1, Taiga Otake1, Tomoki Yonezawa1, Yugo Shimizu1, Kazuyoshi Ikeda1,2, Yuichiro Yamamoto3, Shota Sakai4, Kohji Noguchi3, Masayoshi Fukasawa4, Masanori Osawa1 (1. Fac. Pharm., Keio Univ., 2. RIKEN, 3. Pharm. Sci., Tokyo Univ. of Sci., 4. NIID)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
